ST Pharm Signs Supply Contract Worth 45.8 Billion KRW
[Asia Economy Reporter Eunmo Koo] ST Pharm announced on the 16th that it has signed a supply contract for commercial oligonucleotide therapeutic raw materials worth 45,871,880,000 KRW with a Europe-based global pharmaceutical company. The contract amount represents 49.1% of last year's consolidated sales, and the contract period is from the announcement date until February 28, 2022.
Hot Picks Today
"Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- Man in His 40s Who Kept Girlfriend's Body for a Year After Murder Sentenced to 30 Years in Prison Again on Appeal
- Despite Captivating the Nation for Over a Month... "Timmy" the Whale Ultimately Found Dead
- "If You Booked This Month, You Almost Lost Out... Why You Should Wait Until 'This Day' Before Paying for Flight Tickets"
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
